SLC16A1 and pancreatic ductal adenocarcinoma: Comparison of monocarboxylate transporter 1 (MCT1)-specific cytotoxicity of 3-bromopyruvate (3BP), ME3BP-7, and current standard of care agents for pancreatic ductal adenocarcinoma (PDAC) upon short exposures.